209 related articles for article (PubMed ID: 16696580)
1. Cardiovascular effects and risk of syncope related to donepezil in patients with Alzheimer's disease.
Bordier P; Garrigue S; Lanusse S; Margaine J; Robert F; Gencel L; Lafitte A
CNS Drugs; 2006; 20(5):411-7. PubMed ID: 16696580
[TBL] [Abstract][Full Text] [Related]
2. Causes of syncope in patients with Alzheimer's disease treated with donepezil.
Bordier P; Lanusse S; Garrigue S; Reynard C; Robert F; Gencel L; Lafitte A
Drugs Aging; 2005; 22(8):687-94. PubMed ID: 16060718
[TBL] [Abstract][Full Text] [Related]
3. Cardiac safety of donepezil in elderly patients with Alzheimer disease.
Isik AT; Yildiz GB; Bozoglu E; Yay A; Aydemir E
Intern Med; 2012; 51(6):575-8. PubMed ID: 22449664
[TBL] [Abstract][Full Text] [Related]
4. Significance of syncope in patients with Alzheimer's disease treated with cholinesterase inhibitors.
Bordier P; Garrigue S; Barold SS; Bressolles N; Lanusse S; Clémenty J
Europace; 2003 Oct; 5(4):429-31. PubMed ID: 14753643
[TBL] [Abstract][Full Text] [Related]
5. Cardiovascular effects of donepezil in patients with dementia.
McLaren AT; Allen J; Murray A; Ballard CG; Kenny RA
Dement Geriatr Cogn Disord; 2003; 15(4):183-8. PubMed ID: 12626850
[TBL] [Abstract][Full Text] [Related]
6. Safety and tolerability of donepezil at doses up to 20 mg/day: results from a pilot study in patients with Alzheimer's disease.
Doody RS; Corey-Bloom J; Zhang R; Li H; Ieni J; Schindler R
Drugs Aging; 2008; 25(2):163-74. PubMed ID: 18257603
[TBL] [Abstract][Full Text] [Related]
7. Donepezil in patients with severe Alzheimer's disease: double-blind, parallel-group, placebo-controlled study.
Winblad B; Kilander L; Eriksson S; Minthon L; Båtsman S; Wetterholm AL; Jansson-Blixt C; Haglund A;
Lancet; 2006 Apr; 367(9516):1057-1065. PubMed ID: 16581404
[TBL] [Abstract][Full Text] [Related]
8. A randomized, double-blind, placebo-controlled study of the efficacy and safety of donepezil in patients with Alzheimer's disease in the nursing home setting.
Tariot PN; Cummings JL; Katz IR; Mintzer J; Perdomo CA; Schwam EM; Whalen E
J Am Geriatr Soc; 2001 Dec; 49(12):1590-9. PubMed ID: 11843990
[TBL] [Abstract][Full Text] [Related]
9. Use of clarithromycin and adverse cardiovascular events among older patients receiving donepezil: a population-based, nested case-control study.
Hutson JR; Fischer HD; Wang X; Gruneir A; Daneman N; Gill SS; Rochon PA; Anderson GM
Drugs Aging; 2012 Mar; 29(3):205-211. PubMed ID: 22372724
[TBL] [Abstract][Full Text] [Related]
10. Torsades de Pointes with QT prolongation related to donepezil use.
Takaya T; Okamoto M; Yodoi K; Hata K; Kijima Y; Nakajima H; Nishikawa Y; Kita T; Ito M; Seo T; Kawashima S
J Cardiol; 2009 Dec; 54(3):507-11. PubMed ID: 19944332
[TBL] [Abstract][Full Text] [Related]
11. [Symptomatic sinus bradycardia associated with donepezil].
Calvo-Romero JM; Ramos-Salado JL
Rev Neurol; 1999 Jun 1-15; 28(11):1070-2. PubMed ID: 10390778
[TBL] [Abstract][Full Text] [Related]
12. Donepezil and cardiac syncope: case report.
Jane Newby V; Anne Kenny R; McKeith IG
Int J Geriatr Psychiatry; 2004 Nov; 19(11):1110-2. PubMed ID: 15497193
[No Abstract] [Full Text] [Related]
13. Which cholinesterase inhibitor is the safest for the heart in elderly patients with Alzheimer's disease?
Isik AT; Bozoglu E; Yay A; Soysal P; Ateskan U
Am J Alzheimers Dis Other Demen; 2012 May; 27(3):171-4. PubMed ID: 22573283
[TBL] [Abstract][Full Text] [Related]
14. 3-year study of donepezil therapy in Alzheimer's disease: effects of early and continuous therapy.
Winblad B; Wimo A; Engedal K; Soininen H; Verhey F; Waldemar G; Wetterholm AL; Haglund A; Zhang R; Schindler R
Dement Geriatr Cogn Disord; 2006; 21(5-6):353-63. PubMed ID: 16508298
[TBL] [Abstract][Full Text] [Related]
15. Cholinesterase inhibitors and incidence of bradycardia in patients with dementia in the veterans affairs new England healthcare system.
Hernandez RK; Farwell W; Cantor MD; Lawler EV
J Am Geriatr Soc; 2009 Nov; 57(11):1997-2003. PubMed ID: 19793162
[TBL] [Abstract][Full Text] [Related]
16. Long-term safety and tolerability of donepezil 23 mg in patients with moderate to severe Alzheimer's disease.
Tariot P; Salloway S; Yardley J; Mackell J; Moline M
BMC Res Notes; 2012 Jun; 5():283. PubMed ID: 22681723
[TBL] [Abstract][Full Text] [Related]
17. A large, community-based, open-label trial of donepezil in the treatment of Alzheimer's disease.
Relkin NR; Reichman WE; Orazem J; McRae T
Dement Geriatr Cogn Disord; 2003; 16(1):15-24. PubMed ID: 12714795
[TBL] [Abstract][Full Text] [Related]
18. Complete atrioventricular block and ventricular tachyarrhythmia associated with donepezil.
Suleyman T; Tevfik P; Abdulkadir G; Ozlem S
Emerg Med J; 2006 Aug; 23(8):641-2. PubMed ID: 16858101
[TBL] [Abstract][Full Text] [Related]
19. Donepezil: syncope. Various cardiac disorders.
Prescrire Int; 2008 Jun; 17(95):113. PubMed ID: 18630357
[No Abstract] [Full Text] [Related]
20. The safety and tolerability of donepezil in patients with Alzheimer's disease.
Jackson S; Ham RJ; Wilkinson D
Br J Clin Pharmacol; 2004 Nov; 58 Suppl 1(Suppl 1):1-8. PubMed ID: 15496217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
